We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED - GenoMed Inc.
GMED 76.31-0.8%1:31 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jmhollen6/21/2005 3:29:39 PM
   of 347
GenoMed's Method to Prevent Most Kidney Dialysis Featured on IKIDNEY.COM

Contact: David Moskowitz MD GenoMed, Inc. tel. 314-983-9933

ST. LOUIS--June 21, 2005--GenoMed Inc.-- ("the Company" or "GenoMed") (National Quotation Bureau's Pink Sheets Symbol: GMED) a St. Louis, Missouri-based Next Generation Disease Management company, announced today that its method to prevent up to 90% of kidney dialysis was featured in the latest version of NEPHROLOGY Incite, a newsletter for kidney patients at

Dr. David Moskowitz, GenoMed's CEO and Chief Medical Officer, was interviewed about his work on angiotensin I-converting enzyme (ACE). Said Dr. Moskowitz, "Using higher than usual doses of certain ACE inhibitors can actually reverse chronic kidney failure. But this approach must be started while a person's serum creatinine is below 2. A normal serum creatinine is less than 1.5. Patients aren't referred to a kidney specialist until their creatinine is close to 3. So it's imperative that patients learn about this before it's too late for them."

The full interview is at:

About GenoMed

GenoMed has found what it believes to be the "master" disease gene, and has already been able to prevent kidney failure due to diabetes and hypertension in whites, blacks and Hispanics; dramatically delay the progression of terminal emphysema; and begin to see success in treating autoimmune diseases, West Nile virus encephalitis, and cancer. GenoMed's broad-spectrum anti-viral approach was specifically mentioned in BioShield II, recently introduced in the US Senate. GenoMed has recently found several thousand genes for the top six solid cancers in Caucasians--breast, colon, lung, ovarian, pancreatic, and prostate--and is currently offering its Healthchip(r) for early diagnosis of cancer on a research basis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext